http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201524353-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb10923227f3f3da89b2b62be5c6785 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f77e3b6543ec1f33f41e08c1371856 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d935824d6054445e147556312d94b0ec |
| publicationDate | 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201524353-A |
| titleOfInvention | Organ and tissue preservation formulations with increased stability and shelf life |
| abstract | The present invention provides an organ and tissue preservation formulation having an improved shelf life of storage by separating the formulation into a first solution having a pH of at least 7 and a second solution having a pH of less than 7. The first solution comprises a component having improved stability when stored at pH 7 or above, and the second solution comprises a component having improved stability when stored at a pH below 7. The first solution includes water, a balanced salt solution, sugar, adenosine, orotic acid, malic acid, L-carnitine, and insulin. The second solution includes water, an antioxidant such as ascorbic acid, a cell reducing agent such as reduced glutathione, L-citrulline, creatine monohydrate, L-carnosine, and L-arginine. During use, the first and second solutions are mixed to form a final formulation that can be used to preserve the function of the tissue or organ at physiological pH. |
| priorityDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.